logo

Immuno Oncology Assays Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Immuno Oncology Assays Market is segmented by Product (Reagents, Antibodies, Instruments, Software, Consumables and Accessories), by Technology, by Indication and by Geography.

Home Industry Reports Healthcare Immuno Oncology Assays Market - Growth, Trends, COVID-19 Impact, and Forecasts ( ...

Immuno Oncology Assays Market Snapshot

Immuno Oncology Assays Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 12.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Immuno Oncology Assays market studied was projected to grow with a CAGR of nearly 12.3% over the forecast period. The major factor attributing to the growth of the market is the increase in the incidence of cancer. According to the World Health Organization, the global cancer burden is expected to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide developed cancer during their lifetime, and one in 8 men and one in 11 women die from the disease. Furthermore, increasing adoption of targeted therapy is boosting the market growth. Immuno oncology assays are used to measure the concentration of the therapeutic antibody, anti-drug antibodies and soluble protein biomarkers. As the popularity of targeted therapy increases the market growth of the assays increase. However, stringent and unfavorable refund policies is the major drawback of market growth.

Scope of the Report

As per the scope of the report immuno oncology assays is a next-generation sequencing application that delivers real-time automated measurements of immune and tumor cells dynamics. With the help of this assay, biological processes driving the immune response against cancer can be analyzed. It helps in continuously examining and analyzing key event from proliferation and activation, to migration and immune cell killing without disturbing the existing body cells. This report is segmented by Product, by Technology, by Indication and by Geography.

By Product
Reagents and Antibodies
Instruments
Software
Consumables and Accessories
By Technology
Immunoassay
PCR
NGS
Flow Cytometry
Other Technologies
By Indication
Lung Cancer
Colorectal Cancer
Melanoma
Other Cancers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Reagents and Antibodies Segment is Dominating the Immuno Oncology Assays Market.

Reagents and antibodies segment has the maximum share in the market due to factors like increasing demand for the products. The demand is directly proportional to the increasing incidence of several types of cancer globally. As previously stated the global burden of cancer has risen to 18.1 million new cases in the year 2018 as reported by the World Health Organization. The increasing cancer load is due to numerous factors, including population growth and aging as well as the changing frequency of certain causes of cancer linked to social and economic development. Cancers of the lung and female breast are the top categories worldwide in terms of the number of new cases, for each of these types, approximately 2.1 million diagnoses are estimated in 2018, contributing about 11.6% of the total cancer incidence burden. As the cancer diagnosis is increasing the need for the reagent and antibodies increases, thus propelling the segment growth.

Immuno Oncology Assays Market

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, the high prevalence of cancer in the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase the market growth. In this region the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market. According to the National Institutes of Health (NIH),  in 2018, an estimated 1,735,350 new cases of cancer will be detected in the United States and 609,640 people will die from the disease. The statistics prove that the prevalence of cancer is high in the country and this boosts the market growth.

Immuno Oncology Assays Market

Competitive Landscape

The  Immuno Oncology Assays market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Agilent Technologies, Inc, Thermo Fisher Scientific, Cisbio, Illumina, Inc., PerkinElmer, Inc., Crown Bioscience Inc., InSphero., Merck & Company, Inc., F. Hoffmann-La Roche Ltd., HTG Molecular Diagnostics, Inc.

Immuno Oncology Assays Market

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Incidence of Cancer Globally

      2. 4.2.2 Increasing Adoption of Targeted Therapy

    3. 4.3 Market Restraints

      1. 4.3.1 Unfavorable Regulatory and Reimbursement Scenario

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Reagents and Antibodies

      2. 5.1.2 Instruments

      3. 5.1.3 Software

      4. 5.1.4 Consumables and Accessories

    2. 5.2 By Technology

      1. 5.2.1 Immunoassay

      2. 5.2.2 PCR

      3. 5.2.3 NGS

      4. 5.2.4 Flow Cytometry

      5. 5.2.5 Other Technologies

    3. 5.3 By Indication

      1. 5.3.1 Lung Cancer

      2. 5.3.2 Colorectal Cancer

      3. 5.3.3 Melanoma

      4. 5.3.4 Other Cancers

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies, Inc

      2. 6.1.2 Thermo Fisher Scientific

      3. 6.1.3 Illumina, Inc.

      4. 6.1.4 PerkinElmer, Inc.

      5. 6.1.5 Crown Bioscience Inc.

      6. 6.1.6 InSphero.

      7. 6.1.7 Merck & Company, Inc.

      8. 6.1.8 F. Hoffmann-La Roche Ltd.

      9. 6.1.9 HTG Molecular Diagnostics, Inc.

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Immuno Oncology Assays Market market is studied from 2018 - 2026.

The Immuno Oncology Assays Market is growing at a CAGR of 12.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Agilent Technologies, Inc, Thermo Fisher Scientific, Crown Bioscience Inc., Illumina, Inc., PerkinElmer, Inc. are the major companies operating in Immuno Oncology Assays Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!